Articles published by Aquestive Therapeutics, Inc.
Aquestive Therapeutics Announces Executive Appointments and Builds Commercial Capabilities
June 03, 2024
Via GlobeNewswire
Tickers
AQST
Via GlobeNewswire
Tickers
AQST
Aquestive Therapeutics Announces Closing of Underwritten Public Offering of Common Stock
March 25, 2024
Via GlobeNewswire
Tickers
AQST
Via GlobeNewswire
Tickers
AQST
Aquestive Therapeutics Reports Full Year 2023 Financial Results and Provides Business Update
March 05, 2024
Via GlobeNewswire
Tickers
AQST
Aquestive Therapeutics to Participate in Oppenheimer 34th Annual Healthcare Conference
January 30, 2024
Via GlobeNewswire
Tickers
AQST
Aquestive Therapeutics Reports Third Quarter 2023 Financial Results and Provides Business Update
November 06, 2023
Via GlobeNewswire
Tickers
AQST
Aquestive Therapeutics Completes $45 Million Debt Refinancing
November 02, 2023
Via GlobeNewswire
Tickers
AQST
Aquestive Therapeutics Reaffirms Timeline and Pathway for Anaphylm™ (epinephrine) Sublingual Film
September 20, 2023
Via GlobeNewswire
Tickers
AQST
Via GlobeNewswire
Tickers
AQST
Aquestive Therapeutics Reports Second Quarter 2023 Financial Results and Provides Business Update
August 07, 2023
Via GlobeNewswire
Tickers
AQST
Via GlobeNewswire
Tickers
AQST
Data & News supplied by www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.